Tema Oncology ETF (CANC)
NASDAQ: CANC · Real-Time Price · USD
25.93
+0.03 (0.10%)
Aug 1, 2025, 4:00 PM - Market closed
CANC Holdings Information
CANC is an equity ETF with a total of 52 individual holdings. The top holdings are Roche Holding AG stock at 4.90%, Revolution Medicines at 4.59%, Eli Lilly and Company at 4.46%, Merus at 4.46%, and BridgeBio Pharma at 4.41%.
Total Holdings
52
Top 10 Percentage
42.01%
Asset Class
Equity
ETF Category
Health
Assets
69.02M
PE Ratio
20.39
Sector Allocation
Top 25 Holdings
No. | Symbol | Name | % Weight |
---|---|---|---|
1 | RHHBY | Roche Holding AG | 4.90% |
2 | RVMD | Revolution Medicines, Inc. | 4.59% |
3 | LLY | Eli Lilly and Company | 4.46% |
4 | MRUS | Merus N.V. | 4.46% |
5 | BBIO | BridgeBio Pharma, Inc. | 4.41% |
6 | LON: AZN | AstraZeneca PLC | 4.23% |
7 | SWX: NOVN | Novartis AG | 4.05% |
8 | GMAB | Genmab A/S | 3.81% |
9 | SMMT | Summit Therapeutics Inc. | 3.75% |
10 | AMGN | Amgen Inc. | 3.36% |
11 | NUVL | Nuvalent, Inc. | 3.32% |
12 | ZLAB | Zai Lab Limited | 3.27% |
13 | BMY | Bristol-Myers Squibb Company | 3.25% |
14 | EXEL | Exelixis, Inc. | 3.23% |
15 | ACLX | Arcellx, Inc. | 3.19% |
16 | ONC | BeOne Medicines Ltd. | 3.05% |
17 | LEGN | Legend Biotech Corporation | 3.01% |
18 | MRK | Merck & Co., Inc. | 2.48% |
19 | IDYA | IDEAYA Biosciences, Inc. | 2.32% |
20 | ABBV | AbbVie Inc. | 2.15% |
21 | TYO: 4568 | Daiichi Sankyo Company, Limited | 1.83% |
22 | IMNM | Immunome, Inc. | 1.63% |
23 | JANX | Janux Therapeutics, Inc. | 1.60% |
24 | COGT | Cogent Biosciences, Inc. | 1.42% |
25 | GILD | Gilead Sciences, Inc. | 1.39% |
As of Jul 30, 2025